|By PR Newswire||
|September 2, 2014 07:04 AM EDT||
SAN ANTONIO, Sept. 2, 2014 /PRNewswire/ -- Bluegrass Vascular Technologies (BVT), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, has announced the appointment of Dr. Gabriele Niederauer, a seasoned senior medical device executive, to President and CEO. Following the recent closure of Series A financing, BVT is focused on obtaining CE Mark for the Surfacer™ Inside-Out Access Catheter System, a proprietary system that allows physicians to gain venous access using a novel "inside-out" approach.
"Gabriele is a great addition to the team," stated Dr. Paul Castella, Senior Managing Partner of Targeted Technology Funds, a leading investor in BVT. "She has over 20 years of experience in the development and commercialization of medical devices and is a great fit to lead the company to commercialization in Europe and the US."
Prior to BVT, Dr. Niederauer was Vice President of R&D for ArthoCare Corporation, ENT-Sinus Division, a Smith-Nephew Company, where she was instrumental in developing and commercializing novel implants and instruments for sinus surgery. She also held senior management roles at ENTrigue Surgical, C2M Medical and OsteoBiologics. An experienced early-stage executive and respected leader of innovation, Dr. Niederauer has over 20 peer-reviewed articles, 9 US patents, and has developed and launched dozens of products, including resorbable implants, instruments and fixation devices.
"BVT has developed a critical mission to address shortcomings in the venous access market. I am honored to join the team and build upon that mission to bring superior, life-saving technologies to the market," commented Dr. Niederauer. "I look forward to working with the team to commercialize the innovative Surfacer System."
Co-founder and former CEO, Jim Clifton, will transition to the role of Chief Operating Officer (COO) where he will be responsible for company operations, project management and market strategy.
About Bluegrass Vascular Technologies: Bluegrass Vascular Technologies is a medical technology company dedicated to developing and commercializing life-saving devices and methods that address shortcomings in vascular access procedures. The company's initial product offering is the Surfacer™ Inside-Out Access Catheter System, a proprietary system that allows physicians to perform a novel "inside-out" approach to gaining venous access. For more information, please visit www.bluegrassvascular.com.
About Targeted Technology: Targeted Technology is a San Antonio-based venture capital firm which focuses on early stage investments in companies that can advance ground breaking or disruptive technologies to significantly improve the practice of medicine and patient outcomes as well as positively improve the efficiency, cost, or functionality of the development and manufacture of life science products. For more information please visit www.targetedtech.com.
SOURCE Bluegrass Vascular Technologies
Dec. 6, 2016 12:30 PM EST Reads: 2,089
Dec. 6, 2016 12:30 PM EST Reads: 1,003
Dec. 6, 2016 12:28 PM EST Reads: 124
Dec. 6, 2016 11:54 AM EST Reads: 108
Dec. 6, 2016 11:45 AM EST Reads: 295
Dec. 6, 2016 11:30 AM EST Reads: 1,013
Dec. 6, 2016 11:15 AM EST Reads: 423
Dec. 6, 2016 11:00 AM EST Reads: 570
Dec. 6, 2016 10:30 AM EST Reads: 963
Dec. 6, 2016 10:30 AM EST Reads: 1,174
Dec. 6, 2016 10:15 AM EST Reads: 545
Dec. 6, 2016 09:15 AM EST Reads: 2,146
Dec. 6, 2016 09:00 AM EST Reads: 3,967
Dec. 6, 2016 09:00 AM EST Reads: 5,816
Dec. 6, 2016 09:00 AM EST Reads: 713